3-TERT-BUTOXYCARBONYLAMINO-CYCLOBUTANE-1,1-DICARBOXYLIC ACID DIISOPROPYL ESTER, 95.0%, 250mg

(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(4-iodophenyl)butanoic acid, 97%, 5g

TERT-BUTYL ((3R,5S)-5-HYDROXYPIPERIDIN-3-YL)CARBAMATE, 95.0%, 100mg

4-Methoxy-1H-pyrrolo[2,3-c]pyridin-7(6H)-one, 97%, 100mg

Colonne HPLC NUCLEODUR® 100-3 C8 ec, 250 mm, 4,6 mm, 1 pièce(s)

1-Phenoxy-4-(trifluoromethyl)benzene, 95.0%, 1g

2,5-DIBROMO-1,3,4-THIADIAZOLE, 95.0%, 5g

(2S)-dimethyl 2-(4-(1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl)benzamido)pentanedioate, 98%, 25mg

(3-Bromo-2-((3-methoxybenzyl)oxy)phenyl)boronic acid, 95%, 250mg

4-(4-Nitrophenoxy)benzoic acid, 95.0%, 5g

2-(4-Bromo-3-(hydroxymethyl)phenoxy)benzonitrile, 97%, 1g

(2S,3S)-3-Hydroxy-2-(4-methoxyphenyl)-2,3-dihydrobenzo[b][1,4]thiazepin-4(5H)-one, 95.0%, 100g

1-(3-Chloropropyl)-4-methylpiperazine dihydrochloride, 95.0%, 1g